Humana Q3 adjusted loss narrows on Medicaid businesses, revenue slightly beats estimates

Humana

Yesterday 11:09

Overview
U.S. health insurer's Q3 adjusted revenue slightly beat analyst expectations
Adjusted loss per share for Q3 was better than analyst estimates
Company raised full-year 2026 adjusted EPS guidance

Outlook
Humana raises FY 2026 adjusted EPS guidance to at least $9.50, up from $9.00
Company lifts FY 2026 GAAP EPS guidance to at least $15.09, up from $6.52
Humana expects FY 2026 adjusted EPS to decline year-on-year due to Star Ratings headwind

Result Drivers
CENTERWELL AND MEDICAID EXPANSION - Co said strategic expansion of CenterWell and Medicaid businesses contributed to results
CENTERWELL PATIENT GROWTH - Co reported 30% YTD growth in CenterWell Senior Primary Care patients
MEDICAID MEMBERSHIP - Co said Medicaid membership grew 7% YTD, driven by new integrated Duals programs

Company press release: ID:nBw15sM1Ha

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Adjusted Revenue
Slight Beat*
$41.16 bln
$40.89 bln (17 Analysts)
Q3 Adjusted Loss Per Share
Beat
$0.70
$1.003 (25 Analysts)
*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Reuters Recommended Reads
Nov 5 - Oscar Health beats Q3 revenue estimates, raises 2026 outlook
Nov 4 - Health insurers, hospitals rally after sweeping midterm win for Democrats 
Nov 4 - Agilon Health Q3 revenue beats estimates, raises FY guidance

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)